{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:34:45Z","timestamp":1761100485290},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[1995,10]]},"DOI":"10.1016\/0959-8049(95)00360-u","type":"journal-article","created":{"date-parts":[[2002,10,21]],"date-time":"2002-10-21T10:10:42Z","timestamp":1035195042000},"page":"S7-S10","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S4","title":["Early clinical studies with docetaxel"],"prefix":"10.1016","volume":"31","author":[{"given":"M.","family":"Aapro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0959-8049(95)00360-U_bib1","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/ja00738a045","article-title":"Plant antitumour agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia","volume":"93","author":"Wani","year":"1971","journal-title":"J Am Chem Soc"},{"key":"10.1016\/0959-8049(95)00360-U_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/277665a0","article-title":"Promotion of microtubule assembly in vitro by taxol","volume":"277","author":"Schiff","year":"1979","journal-title":"Nature"},{"key":"10.1016\/0959-8049(95)00360-U_bib3","first-page":"417","article-title":"Preclinical evaluation of intravenous Taxotere (RP 56976, NSC 628503), a taxol analog","volume":"31","author":"Bissery","year":"1990"},{"key":"10.1016\/0959-8049(95)00360-U_bib4","first-page":"4845","article-title":"Experimental antitumor activity of Taxotere (RP 56976, NSC 628503), a taxol analogue","volume":"51","author":"Bissery","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/0959-8049(95)00360-U_bib5","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/0959-8049(93)90463-P","article-title":"Preclinical activity of Taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: comparison with taxol and conventional antineoplastic agents","volume":"29A","author":"Vogel","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/0959-8049(95)00360-U_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jnci\/83.4.288","article-title":"Studies with RP 56976 (Taxotere): a semisynthetic analogue of taxol","volume":"83","author":"Ringel","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/0959-8049(95)00360-U_bib7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0006-291X(05)81474-3","article-title":"Effects of Taxotere on murine and human tumor cell lines","volume":"187","author":"Riou","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"issue":"suppl. 5","key":"10.1016\/0959-8049(95)00360-U_bib8","first-page":"5","article-title":"Phase I and pharmacokinetic study of RP 56976 in a new ethanol-free formulation of Taxotere","volume":"3","author":"Aapro","year":"1992","journal-title":"Ann Oncol"},{"key":"10.1016\/0959-8049(95)00360-U_bib9","first-page":"523","article-title":"Phase I and pharmacokinetic study of Taxotere (RP 56976) administered as a 24 hour infusion","volume":"53","author":"Bissett","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/0959-8049(95)00360-U_bib10","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1200\/JCO.1993.11.5.950","article-title":"Phase I clinical trial of Taxotere administered as either a 2-hour or 6-hour intravenous infusion","volume":"11","author":"Burris","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00360-U_bib11","first-page":"1037","article-title":"Phase I and pharmacokinetic study of Taxotere (RP 65976; NSC 628503) given as a short intravenous infusion","volume":"53","author":"Extra","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/0959-8049(95)00360-U_bib12","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/jnci\/84.23.1781","article-title":"Phase I trial of Taxotere: five-day schedule","volume":"84","author":"Pazdur","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/0959-8049(95)00360-U_bib13","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1200\/JCO.1994.12.7.1458","article-title":"Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis","volume":"12","author":"Tomiak","year":"1994","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:095980499500360U?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:095980499500360U?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T18:52:44Z","timestamp":1556563964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/095980499500360U"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":13,"alternative-id":["095980499500360U"],"URL":"https:\/\/doi.org\/10.1016\/0959-8049(95)00360-u","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[1995,10]]}}}